Concepedia

Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.

Yan Lu, Nan Zhou, Xiao Huang, Jin-Wei Cheng, Feng‐Qian Li, Rui-Li Wei, Ji-Ping Cai

PubMed · 2014 · 54 citations · 18 references

DOIFull text

Open access

Abstract

The results offer a new approach for inhibiting angiogenesis of diabetic retinopathy and indicate that the intravitreal injection of bevacizumab inhibits VEGF expression in retina, and bevacizumab-chitosan nanoparticles have a longer duration of action.

References

18

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld et al. · American Journal of Ophthalmology · 2007 · 966 citations

, , +6

Complications in patients after intravitreal injection of bevacizumab

Chiharu Shima, Hirokazu Sakaguchi, Fumi Gomi et al. · Acta Ophthalmologica · 2007 · 207 citations · Full text

A Potential Role for Angiopoietin 2 in the Regulation of the Blood–Retinal Barrier in Diabetic Retinopathy

Sampathkumar Rangasamy, Ramprasad Srinivasan, Joann Maestas et al. · Investigative Ophthalmology & Visual Science · 2011 · 170 citations · Full text